EUVIMEDEUVIMED entdecken
Open Access

Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study

Mohammad Soroosh Hajizade iD, Mohammad Javad Raee, Seyed Nooreddin Faraji, Fakhrossadat Farvadi, Maryam Kabiri, Sedigheh Eskandari, Ali Mohammad Tamaddon

Therapeutic Delivery · 2024

DOI: 10.4155/tde-2023-0107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Delivery, 2024. Verfasst von Mohammad Soroosh Hajizade und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, PO:7146864685. Hauptthemen laut MEDLINE: Streptokinase, Thrombosis, Molecular Dynamics Simulation, Molecular Docking Simulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Streptokinase has poor selectivity and provokes the immune response. In this study, we used in silico studies to design a fusion protein to achieve targeted delivery to the thrombus. Materials & methods: Streptokinase was analyzed computationally for mapping. The fusion protein modeling and quality assessment were carried out on several servers. The enzymatic activity and the stability of the fusion protein and its complex with plasminogen were assessed through molecular docking analysis and molecular dynamics simulation respectively.

Results

Physicochemical properties analysis, protein quality assessments, protein-protein docking and molecular dynamics simulations predicted that the designed fusion protein is functionally active.

Conclusion

Our results showed that this fusion protein might be a prospective candidate as a novel thrombolytic agent with better selectivity. [Box: see text].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StreptokinaseThrombosisMolecular Dynamics SimulationMolecular Docking SimulationFibrinolytic AgentsRecombinant Fusion ProteinsHumansDrug Delivery SystemsFibrinPlasminogenComputer SimulationProtein Binding

Stichwörter der Autor:innen

fibrin-binding peptidefusion proteinin silicostreptokinasetargeted drug delivery

Substanzen

StreptokinaseFibrinolytic AgentsRecombinant Fusion ProteinsFibrinPlasminogen

Autor:innen und Institutionen

  • Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, PO:7146864685.
  • School of Advanced Medical Sciences & Technologies, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
  • Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
  • Arnold & Marie Schwartz College of Pharmacy & Health Sciences, Long Island University, Brooklyn, NY 11201, USA.
  • Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
  • Department of Pharmaceutical Nanotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.

ORCID-Profile: Mohammad Soroosh Hajizade

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Hajizade, M. S., Raee, M. J., Faraji, S. N., Farvadi, F., Kabiri, M., Eskandari, S., & Tamaddon, A. M. (2024). Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study. Therapeutic Delivery. https://doi.org/10.4155/tde-2023-0107

Vancouver

Hajizade MS, Raee MJ, Faraji SN, Farvadi F, Kabiri M, Eskandari S, et al. Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study. Therapeutic Delivery. 2024. doi:10.4155/tde-2023-0107

BibTeX
@article{Hajizade2024,
  author = {Hajizade, Mohammad Soroosh and Raee, Mohammad Javad and Faraji, Seyed Nooreddin and Farvadi, Fakhrossadat and Kabiri, Maryam and Eskandari, Sedigheh and Tamaddon, Ali Mohammad},
  title = {Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study},
  journal = {Therapeutic Delivery},
  year = {2024},
  doi = {10.4155/tde-2023-0107}
}
Kostenlos starten →